Delivery Order SPE2DB25D3201-SPE2DB25FNSJW

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a medication, with a ceiling value of $12,222.04 and a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,073.44 award is for the supply of 300 MCG/0.6 ML ARANESP syringes to support military treatment programs and facilities. The order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, at a ceiling value of $15,421.82. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA valued at $999,999,999, which covers a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,978.91 delivery order is for ARANESP 25 MCG/0.42 ML SYRING 0.42ML medical supplies. The contract has an ultimate completion date of July 9, 2024 and is a firm fixed price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $6,635.76 for the supply of ARANESP 500 MCG/1 ML SYRINGEML. This award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,791.50, is for the procurement of ARANESP 25 MCG/0.42 ML SYRING 0.42ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Aranesp 100 MCG/0.5 ML syringes. The contract has a ceiling value of $3,254.01 and a completion date of September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these critical medical supplies to support military treatment programs and facilities worldwide. This delivery order is part of a larger Indefinite...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.62 firm fixed-price contract is for the delivery of ARANESP 100 MCG/ML VIALML, a medication used to treat anemia. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,529.79 firm fixed-price delivery order is for Aranesp 300 MCG/0.6 ML syringes and has a completion date of January 3, 2024. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,173.37 award is for the supply of 60 mcg/0.3 ml syringes of Aranesp, a medication used to treat anemia. The contract does not have a set-aside designation, indicating open competition. The ultimate completion date is June 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSJW
    Delivery Order

This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML. The award has a total ceiling value of $16,141.52 and an ultimate completion date of April 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/14/25, 10:45 AM